LAVA-1207
Lava Therapeutics
['crpc', 'gu ', 'lava therap']
lava therapeutics announces initial data from the ongoing phase 1/2a clinical trial of lava-1207 in therapy refractory mcrpc at the 2023 asco gu symposium #stocksoftheday #stockalert #stocknews #newclinicaltrialdata #phase1/2 #syndromes 
Find the most important news and press releases about U.S. publicly-traded companies in real-time and stay ahead of the game!